Importance of Therapeutic Drug Monitoring to Detect Drug Interaction between Pazopanib and Warfarin: A Case Report

• Auteurs principaux: Shinya Takasaki (Auteur), Hisanobu Adachi (Auteur), Yoshihide Kawasaki (Auteur), Masafumi Kikuchi (Auteur), Akihiro Ito (Auteur), Nariyasu Mano (Auteur)
• Format: Livre
• Publié: Frontiers Media S.A., 2020-05-01T00:00:00Z.
• Sujets: article
• Accès en ligne: Connect to this object online.

Pazopanib is an orally available multi-tyrosine kinase inhibitor and has been used to treat renal cell carcinoma (RCC). Here, we report the case of a patient with RCC with an increased prothrombin time-international normalized ratio (PT-INR) due to pazopanib therapy. In addition, we have reported th...